Review of the evidence in relation to the treatment criteria for Ibrutinib: Letter from Professor Peter Clark

Document first published:
Page updated:
Topic:
,
Publication type:

This letter, sent to Professor Stephen Powis, provides information about the re-examination of the commissioning treatment criteria for the use of ibrutinib in previously treated patients with chronic lymphocytic leukaemia (CLL).